|CPEX Pharmaceuticals, Inc. is an emerging
specialty pharmaceutical company, incorporated in the state
of Delaware, with principal executive offices located at
1105 North Market Street, Suite 1300, Wilmington, Delaware. We are in the business
of research and development of pharmaceutical
products utilizing our validated drug delivery platform technology.
We have U.S. and international patents and other proprietary
rights to technology that facilitates the absorption of
drugs. Our platform drug delivery technology enhances permeation
and absorption of pharmaceutical molecules across the skin,
nasal mucosa and eye through development of
proprietary formulations with molecules such as CPE-215®. Our
first product is Testim®, a gel for testosterone replacement therapy, which
is a formulation of our technology with testosterone.
Testim is licensed to Auxilium Pharmaceuticals, Inc. (“Auxilium”),
which is currently marketing it in the United
States, Europe and other countries. We have an additional
licensed application with Serenity Pharmaceuticals, Inc.
("Serenity") for Ser-120, a product candidate for the
treatment of nocturia. Ser-120, which is currently in
multiple Phase 3 trials, utilizes our patented
intranasal drug delivery technology.
In 2010, Allergan, Inc. assumed our exclusive license
agreement with Serenity.
We believe, based upon our experience with Testim and
Ser-120, that our technology has the ability to significantly
enhance the permeation of a wide range of therapeutic molecules.
To expand the development and commercialization of products
using our technology, we are pursuing strategic alliances
with partners including large pharmaceutical, specialty
pharmaceutical and biotechnology companies. The alliance
opportunities may include co-development of products, in-licensing
of therapeutic molecules, out-licensing of delivery technology
or partnering late-stage candidates for commercialization.